Lead antibacterial compound against a novel target in Gram-negative bacteria validated in infection modelsProgressing a ...
Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity ...
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections. It announced today ...
The researchers also utilised a new type of AI to predict the antibiotic’s mechanism of action (MOA) - the first instance of ...
A team of scientists discovered a hidden antibiotic 100 times stronger than existing drugs against deadly superbugs like MRSA. The molecule had been overlooked for decades in a familiar bacterium. It ...
Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity ...
News-Medical.Net on MSN
Novel antibiotic shows activity against WHO high priority pathogen VRE
Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity ...
Lead antibacterial compound against a novel target in Gram-negative bacteria validated in infection modelsProgressing a platform of small-molecule enzymatic activators that induce self-digestion of ba ...
Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity against drug-resistant ...
Zoliflodacin, an investigational single-dose oral antibiotic for uncomplicated gonorrhea, to be featured in oral presentation ...
Antimicrobial resistance (AMR) is one of the world’s most urgent health challenges, with the WHO’s new report showing there are ‘too few antibacterials in the pipeline’. Most of the ‘low-hanging fruit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results